pyridostigmine bromide has been researched along with Dyskinesia Syndromes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Rahman, A; Abou-Donia, M; Abou-Donia, S; El-Masry, E; Shetty, A | 1 |
| Bentivoglio, AR; Evoli, A; Fasano, A; Piano, C; Tonali, PA | 1 |
| Ltschg, J; Mumenthaler, M; Rossi, L | 1 |
3 other study(ies) available for pyridostigmine bromide and Dyskinesia Syndromes
| Article | Year |
|---|---|
Stress and combined exposure to low doses of pyridostigmine bromide, DEET, and permethrin produce neurochemical and neuropathological alterations in cerebral cortex, hippocampus, and cerebellum.
Topics: Animals; Cerebellum; Cerebral Cortex; Cholinesterase Inhibitors; Cognition Disorders; DEET; Disease Models, Animal; Dose-Response Relationship, Drug; Hippocampus; Humans; Insect Repellents; Movement Disorders; Persian Gulf Syndrome; Pyridostigmine Bromide; Rats; Rats, Sprague-Dawley; Stress, Psychological | 2004 |
Myasthenia gravis: an unrecognized cause of head drop in Parkinson's disease.
Topics: Anti-Inflammatory Agents; Antiparkinson Agents; Cholinesterase Inhibitors; Electromyography; Female; Head Movements; Humans; Middle Aged; Movement Disorders; Myasthenia Gravis; Parkinson Disease; Plasma Exchange; Prednisone; Pyridostigmine Bromide; Spinal Osteophytosis | 2008 |
[Treatment of myasthenia gravis pseudoparalytica. Analysis of 60 personal cases and study of the literature].
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Middle Aged; Movement Disorders; Myasthenia Gravis; Neostigmine; Pyridostigmine Bromide | 1976 |